139 related articles for article (PubMed ID: 28977756)
1. Hypersensitivity reactions to low molecular weight heparins: different patterns of cross-reactivity in 3 patients.
Juricic Nahal D; Cegec I; Erdeljic Turk V; Makar Ausperger K; Kraljickovic I; Simic I
Can J Physiol Pharmacol; 2018 Apr; 96(4):428-432. PubMed ID: 28977756
[TBL] [Abstract][Full Text] [Related]
2. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight.
Grims RH; Weger W; Reiter H; Arbab E; Kränke B; Aberer W
Br J Dermatol; 2007 Sep; 157(3):514-7. PubMed ID: 17573880
[TBL] [Abstract][Full Text] [Related]
3. Adverse skin reactions to low molecular weight heparins: frequency, management and prevention.
Wütschert R; Piletta P; Bounameaux H
Drug Saf; 1999 Jun; 20(6):515-25. PubMed ID: 10392668
[TBL] [Abstract][Full Text] [Related]
4. [A study of 19 cases of allergy to heparins with positive skin testing].
Phan C; Vial-Dupuy A; Autegarden JE; Amsler E; Gaouar H; Abuaf N; Pecquet C; Francès C; Soria A
Ann Dermatol Venereol; 2014 Jan; 141(1):23-9. PubMed ID: 24461090
[TBL] [Abstract][Full Text] [Related]
5. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study.
Grassegger A; Fritsch P; Reider N
Dermatol Surg; 2001 Jan; 27(1):47-52. PubMed ID: 11231243
[TBL] [Abstract][Full Text] [Related]
6. [Delayed hypersensitivity to heparins and heparinoids].
Nicolie B; Bonneau JC; Le Sellin J; Gay G; Leclere JM; Drouet M
Allerg Immunol (Paris); 2002 Feb; 34(2):47-50. PubMed ID: 11933754
[TBL] [Abstract][Full Text] [Related]
7. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin.
Koch P; Münssinger T; Rupp-John C; Uhl K
J Am Acad Dermatol; 2000 Apr; 42(4):612-9. PubMed ID: 10727306
[TBL] [Abstract][Full Text] [Related]
8. Skin tests in patients with delayed and immediate hypersensitivity to heparins: A case series.
Tramontana M; Hansel K; Bianchi L; Agostinelli D; Stingeni L
Contact Dermatitis; 2019 Mar; 80(3):170-172. PubMed ID: 30450556
[No Abstract] [Full Text] [Related]
9. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
Koch P
Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
[TBL] [Abstract][Full Text] [Related]
10. Immediate Type Hypersensitivity to Heparins: Two Case Reports and a Review of the Literature.
Cesana P; Scherer K; Bircher AJ
Int Arch Allergy Immunol; 2016; 171(3-4):285-289. PubMed ID: 28049195
[TBL] [Abstract][Full Text] [Related]
11. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
Ludwig RJ; Schindewolf M; Alban S; Kaufmann R; Lindhoff-Last E; Boehncke WH
Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404
[TBL] [Abstract][Full Text] [Related]
12. Different patterns of cross-reactivity in non-immediate hypersensitivity to heparins: from localized to systemic reactions.
Poza-Guedes P; González-Pérez R; Canto G
Contact Dermatitis; 2002 Oct; 47(4):244-5. PubMed ID: 12492535
[No Abstract] [Full Text] [Related]
13. Incidence of hypersensitivity skin reactions in patients on full-dose low-molecular-weight heparins during pregnancy.
Schultinge L; Knol HM; Kluin-Nelemans HC; Erwich JJ; Meijer K
Neth J Med; 2013 Dec; 71(10):518-22. PubMed ID: 24394737
[TBL] [Abstract][Full Text] [Related]
14. Delayed-type hypersensitivity to heparins: different patterns of cross-reactivity.
Palacios Colom L; Alcántara Villar M; Luis Anguita Carazo J; Ruiz Villaverde R; Quiralte Enríquez J
Contact Dermatitis; 2008 Dec; 59(6):375-7. PubMed ID: 19076893
[No Abstract] [Full Text] [Related]
15. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases.
Jappe U; Juschka U; Kuner N; Hausen BM; Krohn K
Contact Dermatitis; 2004 Aug; 51(2):67-72. PubMed ID: 15373846
[TBL] [Abstract][Full Text] [Related]
16. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight. Commentary.
Gómez-Outes A; Gómez de la Bárcena C; Martínez-González J
Br J Dermatol; 2008 Apr; 158(4):869-70. PubMed ID: 18284394
[No Abstract] [Full Text] [Related]
17. Delayed-type hypersensitivity reactions induced by proton pump inhibitors: A clinical and in vitro T-cell reactivity study.
Lin CY; Wang CW; Hui CR; Chang YC; Yang CH; Cheng CY; Chen WW; Ke WM; Chung WH
Allergy; 2018 Jan; 73(1):221-229. PubMed ID: 28658503
[TBL] [Abstract][Full Text] [Related]
18. Delayed hypersensitivity to one low-molecular-weight heparin with tolerance of other low-molecular-weight heparins.
Bircher AJ; Itin PH; Tsakiris DA; Surber C
Br J Dermatol; 1995 Mar; 132(3):461-3. PubMed ID: 7718467
[TBL] [Abstract][Full Text] [Related]
19. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update.
Jappe U
Blood Coagul Fibrinolysis; 2006 Nov; 17(8):605-13. PubMed ID: 17102645
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins.
Lopez S; Torres MJ; Rodríguez-Pena R; Blanca-Lopez N; Fernandez TD; Antunez C; Canto G; de Luque V; Mayorga C
Br J Dermatol; 2009 Feb; 160(2):259-65. PubMed ID: 18945304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
